Elderly woman with atrial fibrillation, a GI bleed, and an antiplatelet-sized dilemma
A 79-year-old woman with permanent atrial fibrillation, hypertension, type 2 diabetes and a right-hemispheric TIA four years ago presents with three days of black tarry stools, lightheadedness on standing, and one syncopal episode at home. Her medications are apixaban 5 mg twice daily, metoprolol, amlodipine, metformin, and naproxen 500 mg twice daily, which she has taken most days for two months for knee pain. Supine blood pressure is 104/64 mmHg, falling to 88/56 on standing; pulse 98 and irregular; respiratory rate 20; temperature 36.8 C. She is pale, diaphoretic and alert but slowed. Rectal examination confirms melena. Haemoglobin 6.9 g/dL (baseline 11.8), platelets 210, creatinine 1.4 mg/dL, INR 1.1, weight 52 kg. The last apixaban dose was about ten hours ago.
1. Outline your management over the first two hours, including what you do about anticoagulant reversal. Explain how your plan would change if she were haemodynamically unstable.
Read the worked answer
Stabilise before you reverse.
- Two large-bore cannulas, type and screen with crossmatch, cautious crystalloid (elderly, actively bleeding), and a plan for blood products rather than fluid alone.
- Transfuse to a restrictive threshold: trigger at haemoglobin below 7 g/dL, target 7-8 g/dL (8 g/dL if there were ischaemic heart disease). Over-transfusion worsens rebleeding and volume overload.
- Hold apixaban. With the last dose ten hours ago and reduced renal clearance, drug effect is likely still present.
- Intravenous proton-pump inhibitor bolus then infusion; check fibrinogen and platelets, replace only if deficient.
- Reversal: for life-threatening haemorrhage on a factor Xa inhibitor, andexanet alfa if available, otherwise four-factor prothrombin complex concentrate around 50 units/kg per local protocol. Do not use INR to judge effect; it does not reflect apixaban activity.
- Endoscopy after resuscitation, ideally within 24 hours.
If she were unstable (systolic below 90 despite fluids, ongoing haematemesis), I would activate the massive transfusion protocol, give reversal immediately, and escalate to urgent endoscopy or interventional radiology rather than a ward-based workup.
2. Is her apixaban dose appropriate? Identify modifiable bleeding risks and state what you would change.
Read the worked answer
Her dose is correct at 5 mg twice daily. Dose reduction requires two of three criteria: age 80 or older, weight 60 kg or less, creatinine 1.5 mg/dL or more. She meets only the weight criterion, so reducing to 2.5 mg would be an under-dose and would leave her stroke risk inadequately covered. Under-dosing is a common error precisely because it feels cautious.
Modifiable contributors:
- Naproxen: stop it. Chronic NSAID use with an anticoagulant is a major, avoidable driver of upper GI bleeding. Offer topical NSAID or paracetamol, physiotherapy, and a knee plan.
- Blood pressure control: aiming below 130/80 lowers intracranial bleeding risk.
- Add a proton-pump inhibitor for gastroprotection.
- Investigate anaemia properly (iron studies, coeliac serology, endoscopy) rather than attributing it to NSAIDs alone.
- Review falls risk, alcohol, and any over-the-counter/herbal agents.
Non-modifiable risk factors (age, prior TIA) are reasons to treat carefully, not reasons to withhold anticoagulation.
3. Two weeks later she has been treated endoscopically for a duodenal ulcer with secure haemostasis. How do you decide whether and when to restart anticoagulation, and what are the alternatives if she cannot take it?
Read the worked answer
Balance absolute risks rather than reacting to the bleed alone. Her CHA2DS2-VASc score (age, sex, hypertension, diabetes, prior TIA) puts her at high annual stroke risk, and observational data suggest that stopping anticoagulation after a GI bleed increases thrombotic events and mortality more than it prevents rebleeding.
Practical approach:
- Confirm endoscopic haemostasis and treat Helicobacter pylori if present.
- Restart the anticoagulant once haemostasis is secure, typically at about 7-14 days, after a shared discussion; earlier if thrombotic risk is very high, later if haemostasis was marginal.
- Continue the PPI and permanently stop NSAIDs.
- No need to switch agent routinely; if adherence or interactions are issues, review choice.
If she truly cannot be anticoagulated (recurrent major bleeds), refer for left atrial appendage occlusion and document the reasoning. Falls alone are not a reason to withhold anticoagulation.